Cargando…

Bone Marrow Monocyte / Macrophage Derived Activin A Mediates the Osteoclastogenic Effect of IL-3 in Multiple Myeloma

Detalles Bibliográficos
Autores principales:	Silbermann, Rebecca, Bolzoni, Marina, Storti, Paola, Guasco, Daniela, Bonomini, Sabrina, Zhou, Dan, Wu, Jingwei, Anderson, Judith L., Windle, Jolene J., Aversa, Franco, Roodman, G. David, Giuliani, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981881/ https://www.ncbi.nlm.nih.gov/pubmed/24369304 http://dx.doi.org/10.1038/leu.2013.385

Ejemplares similares

IL21R expressing CD14(+)CD16(+) monocytes expand in multiple myeloma patients leading to increased osteoclasts
por: Bolzoni, Marina, et al.
Publicado: (2017)

Myeloma bone disease: Pathophysiology and management
por: Silbermann, Rebecca, et al.
Publicado: (2013)

Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties
por: Costa, Federica, et al.
Publicado: (2017)

Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling
por: Accardi, Fabrizio, et al.
Publicado: (2015)

Single-cell transcriptomics of human cholesteatoma identifies an activin A-producing osteoclastogenic fibroblast subset inducing bone destruction
por: Shimizu, Kotaro, et al.
Publicado: (2023)

Jaw and Long Bone Marrows Have a Different Osteoclastogenic Potential
por: de Souza Faloni, Ana Paula, et al.
Publicado: (2010)

Blocking the ZZ Domain of Sequestosome1/p62 Suppresses Myeloma Growth and Osteoclast Formation In Vitro and Induces Dramatic Bone Formation in Myeloma-Bearing Bones In Vivo
por: Teramachi, Jumpei, et al.
Publicado: (2015)

Ionizing Radiation Stimulates Expression of Pro-Osteoclastogenic Genes in Marrow and Skeletal Tissue
por: Alwood, Joshua S., et al.
Publicado: (2015)

The osteocyte and its osteoclastogenic potential
por: Marahleh, Aseel, et al.
Publicado: (2023)

Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation
por: Costa, Federica, et al.
Publicado: (2017)

Effect of Usnic Acid on Osteoclastogenic Activity
por: Kim, Kwang-Jin, et al.
Publicado: (2018)

Identification of an osteoclastogenic CD4+ T cell population producing IL-17 and TNFα
por: Ciucci, Thomas, et al.
Publicado: (2011)

Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients
por: Marchica, Valentina, et al.
Publicado: (2019)

The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues
por: Zupan, Janja, et al.
Publicado: (2012)

Membrane translocation of Bruton kinase in multiple myeloma cells is associated with osteoclastogenic phenotype in bone metastatic lesions
por: Li, Li, et al.
Publicado: (2018)

Role of Galectins in Multiple Myeloma
por: Storti, Paola, et al.
Publicado: (2017)

Sera of patients with axial spondyloarthritis (axSpA) enhance osteoclastogenic potential of monocytes isolated from healthy individuals
por: Korkosz, Mariusz, et al.
Publicado: (2018)

Exploring the Pathophysiologic Cascade Leading to Osteoclastogenic Activation in Gaucher Disease Monocytes Generated via CRISPR/Cas9 Technology
por: Ormazabal, Maximiliano Emanuel, et al.
Publicado: (2023)

Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis
por: Petrusca, Daniela N, et al.
Publicado: (2018)

P58 LOW CD38 EXPRESSION BY PLASMA CELLS IN EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA PATIENTS
por: Notarfranchi, L., et al.
Publicado: (2023)

PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients
por: Costa, Federica, et al.
Publicado: (2021)

Total body proton and heavy-ion irradiation causes cellular senescence and promotes pro-osteoclastogenic activity in mouse bone marrow
por: Kumar, Kamendra, et al.
Publicado: (2021)

Osteoclastogenic Potential of Peripheral Blood Mononuclear Cells in Cleidocranial Dysplasia
por: Faienza, Maria Felicia, et al.
Publicado: (2014)

Regulatory T cell phenotype and anti-osteoclastogenic function in experimental periodontitis
por: Alvarez, Carla, et al.
Publicado: (2020)

The role of secreted osteoclastogenic factor of activated T cells in bone remodeling()
por: Zhang, Ruonan, et al.
Publicado: (2022)

XRK3F2 Inhibition of p62-ZZ Domain Signaling Rescues Myeloma-Induced GFI1-Driven Epigenetic Repression of the Runx2 Gene in Pre-osteoblasts to Overcome Differentiation Suppression
por: Adamik, Juraj, et al.
Publicado: (2018)

Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy
por: Toscani, Denise, et al.
Publicado: (2018)

Activin A/erythroid differentiation factor is induced during human monocyte activation
Publicado: (1992)

Impairment of bone microstructure and upregulation of osteoclastogenic markers in spontaneously hypertensive rats
por: Tiyasatkulkovit, Wacharaporn, et al.
Publicado: (2019)

The inhibition of Wnt signaling attenuates RANKL-induced osteoclastogenic macrophage activation
por: Yamanouchi, Dai, et al.
Publicado: (2023)

Metabolic features of myeloma cells in the context of bone microenvironment: Implication for the pathophysiology and clinic of myeloma bone disease
por: Raimondi, Vincenzo, et al.
Publicado: (2022)

Activin A: a novel urinary biomarker of renal impairment in multiple myeloma
por: Iriuchishima, Hirono, et al.
Publicado: (2019)

Involvement of CHOP in activin A-induced myeloma NS-1 cell apoptosis
por: Ge, Jingyan, et al.
Publicado: (2019)

New Insights into Osteogenic and Chondrogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells and Their Potential Clinical Applications for Bone Regeneration in Pediatric Orthopaedics
por: Giuliani, Nicola, et al.
Publicado: (2013)

Modern Interpretation of Giant Cell Tumor of Bone: Predominantly Osteoclastogenic Stromal Tumor
por: Kim, Yuhree, et al.
Publicado: (2012)

Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts
por: Shiirevnyamba, A, et al.
Publicado: (2011)

Periodontal disease influences osteoclastogenic bone markers in subjects with and without rheumatoid arthritis
por: Panezai, Jeneen, et al.
Publicado: (2018)

Evaluation of the osteoclastogenic process associated with RANK / RANK-L / OPG in odontogenic myxomas
por: González-Galván, María del Carmen, et al.
Publicado: (2018)

EGR1 Regulates Angiogenic and Osteoclastogenic Factors in Prostate Cancer and Promotes Metastasis
por: Li, Lechen, et al.
Publicado: (2019)

Anti-osteoclastogenic effect of epigallocatechin gallate-functionalized gold nanoparticles in vitro and in vivo
por: Zhu, Shenting, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_03cqh5rtdjf8ri4d0tkjce8fo2